Dr. Lal PathLabs Limited has introduced a new diagnostic test for Amyloid Typing using Laser Capture Microdissection and Mass Spectrometry. This development marks a significant step forward in the diagnosis of amyloidosis, a condition caused by the accumulation of misfolded amyloid proteins in vital organs such as the kidneys, heart, lungs, and skin. The presence of amyloid in these organs can lead to a loss of function and, in some cases, prove fatal.
The new test is designed to accurately identify the specific type of amyloid protein present in the body. With over 40 different types of amyloid proteins identified to date, determining the precise type is critical for clinicians to recommend the appropriate course of treatment or management for patients. This test helps address a longstanding challenge in amyloidosis diagnosis, which is often complicated by the similarities in how different types of amyloid present in the body.
Dr. Lal PathLabs is making this specialized diagnostic service available across India. Samples collected from any location can be sent to the National Reference Lab in Rohini, New Delhi, where the testing is conducted. Hospitals and healthcare providers across the country can facilitate sample collection and send them for analysis, ensuring wider access to this testing capability.
By offering this advanced diagnostic tool, Dr. Lal PathLabs supports more accurate and timely diagnosis of amyloidosis, which is essential for initiating effective and targeted treatments.
